Last reviewed · How we verify
NCT06834867: MILAP
Multi-component Family Intervention to Lower Depression and Address Intimate Partner Violence in Nepal
NA trial testing MILAP intervention in Intimate Partner Violence (IPV) in 900 participants. Currently enrolling.
29 January 2027
Quick facts
| Lead sponsor | Possible |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 900 |
| Start date | 4 April 2025 |
| Primary completion | 29 January 2027 |
| Estimated completion | 1 April 2028 |
| Sites | 1 location across Nepal |
Drugs / interventions tested
- MILAP intervention
Conditions studied
- Intimate Partner Violence (IPV) — all drugs for Intimate Partner Violence (IPV) →
- Depression — all drugs for Depression →
- PTSD - Post Traumatic Stress Disorder — all drugs for PTSD - Post Traumatic Stress Disorder →
Sponsor
Possible
Who can join
Adults 15 to 24, any sex, with Intimate Partner Violence (IPV) or Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Intimate Partner Violence (IPV) is a major public health problem in low- and middle-income countries (LMICs). Globally, an estimated 30% of women report physical or sexual violence by an intimate partner in their lifetime. IPV is a well-established social driver of mental health problems, and doubles the rate of depression and post-traumatic stress disorder (PTSD). Interventions like cognitive behavioral therapy (CBT) can improve depression after women experiencing IPV exit abusive relationships. However, despite ongoing violence, many young women in LMICs are less likely to divorce or separate from their husband. But ongoing IPV severely limits mental health recovery and increases the risks of suicide. Another important factor in many LMICs is that young women often live in extended, multi-generational households, where studies have shown that mother-in-laws (MILs) play a critical role in young married women's autonomy and freedom of movement, substantially affecting her mental health. The pathways via which multiple family members and ongoing IPV affect young women's mental health in LMICs is very poorly understood. There is an urgent need to design and assess interventions that: a) improve mental health and reduce IPV; b) engage husbands and MILs, and not just women experiencing IPV; and c) elucidate pathways via which IPV-related drivers affect mental health. This study's research team, with over 16 years of experience in Nepal, conducted a pilot study introducing the Multi-component family Intervention to Lower depression and Address intimate Partner violence (MILAP). MILAP, which translates to "unity and reconciliation" in Nepali, showed promise in reducing depression and IPV among families (comprising women, husbands, and mothers-in-law). Based on these favorable results, the investigators now propose a 12-month randomized controlled trial (RCT) to assess the effectiveness of MILAP in addressing depression, IPV, and PTSD among young married women in Nepal. The goal of this RCT is to assess the effectiveness of MILAP, understand mechanisms of change for MILAP's effectiveness, and conduct a cost-effectiveness analysis. The specific aims of this study are: AIM 1: Conduct a 12-month RCT to assess the effectiveness of MILAP on depression, IPV, and PTSD among young married women in Nepal. AIM 2: Conduct a mixed-methods assessment of theorized mechanisms of change for MILAP's effectiveness. AIM 3: Conduct a cost-effectiveness analysis of MILAP for depression and IPV. Participants of this study will receive either MILAP or enhanced usual care, and will answer questions about depression, IPV and PTSD at baseline, at 1 month and every 3 months until 1-year.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A multi-component family intervention to lower depression and address intimate partner violence (MILAP) among young married women in Nepal: a study protocol for a randomized controlled trial.
Shrestha M, Heylen E, Sigdel K, Dhimal M, et al · · 2026 · PMID 41680806 · DOI 10.1186/s13063-026-09507-8 -
A randomized controlled trial of a multi-component family intervention to lower depression and address intimate partner violence (MILAP) among young married women in Nepal: a study protocol
Shrestha M, Heylen E, Sigdel K, Dhimal M, et al · · 2025 · DOI 10.21203/rs.3.rs-7048952/v1
Verify or expand the search:
- PubMed search for NCT06834867
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Intimate Partner Violence (IPV)
Currently open trials in the same condition.
- NCT06627764 — SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families · NA · recruiting
- NCT06735417 — Impacts of the Indashyikirwa Program on Intimate Partner Violence in Syria · NA · active not recruiting
Other Possible trials
Trials by the same sponsor.
- NCT07370298 — Developing and Testing a Digital Health Tool for INterseCtional Stigma Assessment and Reduction at Multiple Levels and m · NA · recruiting
- NCT04462679 — COMMIT HIV Trial Nepal · NA · unknown
- NCT02376062 — Bundled Intervention Integrating Mental Health Services in Nepal · NA · unknown
- NCT02330887 — Group Antenatal Care: The Power of Peers for Increasing Skilled Birth Attendance in Achham, Nepal · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06834867 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Possible
- Last refreshed: 14 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06834867.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing